Literature DB >> 26323902

MicroRNA let-7: Regulation, single nucleotide polymorphism, and therapy in lung cancer.

Guang Yang, Wenqi Zhang, Chunlei Yu, Jin Ren, Zhe An1.   

Abstract

Lung cancer (LC) is the leading cause of cancer-related deaths worldwide. MicroRNAs (miRNAs) are highly evolutionarily conserved noncoding small RNAs, which were first identified in Caenorhabditis elegans. There are 1100 or more miRNAs have been identified in Homo sapiens. Let-7 miRNA is involved in the regulation of gene expression in cells. Several novel factors and feedback loops involved in the regulation of the synthesis of let-7 have been identified and additional let-7 target genes have been found. Let-7 has also been shown to be significantly correlated with the occurrence and development of cancer and the results of preliminary studies suggest that it is involved in the regulation of oncogenic pathways in numerous types of tumors, such as, LC. As let-7 is a potential molecular target for tumor therapy, a mass of studies have been conducted focus on the relationship between let-7 and LC. With the mechanism becoming revealed, more and more groups are looking for the anti-tumor role of let-7 family in anti-tumor therapy development. In this review, we summarize the newest investigations on let-7 and LC, the regulation of let-7 and its targets gene have been discussed, and the attempts for new therapy for LC have also been summarized.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26323902     DOI: 10.4103/0973-1482.163830

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  18 in total

1.  Clinical value of exhaled breath condensate let-7 in non-small cell lung cancer.

Authors:  Jin-Liang Chen; Hui-Na Han; Xue-Dong Lv; Hang Ma; Jin-Nan Wu; Jian-Rong Chen
Journal:  Int J Clin Exp Pathol       Date:  2020-02-01

2.  Prognostic value of Lin28A and Lin28B in various human malignancies: a systematic review and meta-analysis.

Authors:  Jiayi Zhang; Aiming Xu; Chenkui Miao; Jie Yang; Min Gu; Ninghong Song
Journal:  Cancer Cell Int       Date:  2019-04-02       Impact factor: 5.722

3.  Let-7a suppresses glioma cell proliferation and invasion through TGF-β/Smad3 signaling pathway by targeting HMGA2.

Authors:  Yang Li; Xianfeng Zhang; Dawei Chen; Chengyuan Ma
Journal:  Tumour Biol       Date:  2015-12-29

Review 4.  Targeting MicroRNAs in Cancer Gene Therapy.

Authors:  Weidan Ji; Bin Sun; Changqing Su
Journal:  Genes (Basel)       Date:  2017-01-09       Impact factor: 4.096

5.  Reticuloendotheliosis virus and avian leukosis virus subgroup J synergistically increase the accumulation of exosomal miRNAs.

Authors:  Defang Zhou; Jingwen Xue; Shuhai He; Xusheng Du; Jing Zhou; Chengui Li; Libo Huang; Venugopal Nair; Yongxiu Yao; Ziqiang Cheng
Journal:  Retrovirology       Date:  2018-07-03       Impact factor: 4.602

Review 6.  [Research Progress of Exosomes in Lung Cancer Diagnosis and Treatment].

Authors:  Hongbo Zou; Hong Wu; Chuan Xu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-11-20

Review 7.  The roles of tumor-derived exosomes in non-small cell lung cancer and their clinical implications.

Authors:  Hongmei Zheng; Yuting Zhan; Sile Liu; Junmi Lu; Jiadi Luo; Juan Feng; Songqing Fan
Journal:  J Exp Clin Cancer Res       Date:  2018-09-14

8.  Lin28/microRNA-let-7a promotes metastasis under circumstances of hyperactive Wnt signaling in esophageal squamous cell carcinoma.

Authors:  Rui Ling; Yuepeng Zhou; Ling Zhou; Dongfang Dai; Dan Wu; Lei Mi; Chaoming Mao; Deyu Chen
Journal:  Mol Med Rep       Date:  2018-02-02       Impact factor: 2.952

9.  Decoding the Emerging Patterns Exhibited in Non-coding RNAs Characteristic of Lung Cancer with Regard to their Clinical Significance.

Authors:  Laura Sonea; Mihail Buse; Diana Gulei; Anca Onaciu; Ioan Simon; Cornelia Braicu; Ioana Berindan-Neagoe
Journal:  Curr Genomics       Date:  2018-05       Impact factor: 2.236

Review 10.  Cell Cycle Regulation of Stem Cells by MicroRNAs.

Authors:  Michelle M J Mens; Mohsen Ghanbari
Journal:  Stem Cell Rev Rep       Date:  2018-06       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.